JPRN-jRCT2080221655未知3 期
Phase III study of Garenoxacin in the treatment of community-acquired pneumonia- A randomized, multi-center, double-blind, double-dummy and comparative study
Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)0 个研究点开始时间: 2011年11月16日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 70age old（—）
- 性别
- All
入选标准
- •(1) Patients with community-acquired pneumonia requiring outpatient or inpatient treatment.
- •(2) Sex: male or female.
- •(3) Age: 18 to 70 years old.
- •(4) Pneumonia patients indicated to oral antibacterial agents.
- •(5) Others.
排除标准
- •(1)History of hypersensitive reaction to any quinolone antibacterial agents.
- •(2) History of twitch and/or epilepsia or taking antiepileptic agents.
- •(3) Pregnant females, females wishing to become pregnant or being possibly pregnant, and lactating females.
- •(4) Patients with severe infection requiring tretment with injectable antibacterial agents or mechanical ventilator.
- •(5) Others.
研究者
相似试验
已完成
不适用
Clinical efficacy of garenoxacin for treatment of bacterial respiratory infection secondary to chronic respiratory diseaseJPRN-UMIN000016373Department of Medicine, Division of Allergology and Respiratory Medicine, Showa University School of Medicine120
已完成
2 期
Efficacy and safety of Garenoxacin for the prevention in the patients with hematological malignancies after chemotherapyhematological malignanciesJPRN-UMIN000004979Gifu University Hospital50
招募中
不适用
Clinical study of Garenoxacin on male non-gonococcal urethritisJPRN-UMIN000014994Jikei university katsushika medical center,Department of urology50
已完成
不适用
Efficacy and safety of GHX02 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitisKCT0003665Daejeon Korean Medicine Hospital of Daejeon University117
已完成
不适用
Garenoxacin versus Levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiologyJPRN-UMIN000012421Hokuriku otolaryngology practiced expert study group200